Stocks
Funds
Screener
Sectors
Watchlists

Latest Aldebaran Capital, LLC Stock Portfolio

Aldebaran Capital, LLC Performance:
2025 Q3: 7.17%YTD: 6.34%2024: 2.49%

Performance for 2025 Q3 is 7.17%, and YTD is 6.34%, and 2024 is 2.49%.

About Aldebaran Capital, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Aldebaran Capital, LLC reported an equity portfolio of $108.9 Millions as of 30 Sep, 2025.

The top stock holdings of Aldebaran Capital, LLC are , MSFT, OXY. The fund has invested 19.4% of it's portfolio in BERKSHIRE HATHAWAY INC DEL and 9% of portfolio in MICROSOFT CORP.

The fund managers got completely rid off ESSA PHARMA INC (EPIX), IKENA ONCOLOGY INC (IKNA) and PROCTER AND GAMBLE CO (PG) stocks. They significantly reduced their stock positions in AMYLYX PHARMACEUTICALS INC (AMLX), TECK RESOURCES LTD and JPMORGAN CHASE & CO (JPM). Aldebaran Capital, LLC opened new stock positions in GE VERNOVA INC and IMAGENEBIO INC (IKNA). The fund showed a lot of confidence in some stocks as they added substantially to VERIZON COMMUNICATIONS INC (VZ) and FREEPORT-MCMORAN INC (FCX).

Aldebaran Capital, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Aldebaran Capital, LLC made a return of 7.17% in the last quarter. In trailing 12 months, it's portfolio return was 5.26%.

New Buys

Ticker$ Bought
ge vernova inc204,147
imagenebio inc159,430

New stocks bought by Aldebaran Capital, LLC

Additions to existing portfolio by Aldebaran Capital, LLC

Reductions

Ticker% Reduced
amylyx pharmaceuticals inc-6.13
teck resources ltd-4.37
tectonic therapeutic inc-4.36
jpmorgan chase & co-3.57
century alum co-2.65
an2 thereapeutics inc-2.48
pmv pharmaceuticals inc-2.14
occidental pete corp-1.58

Aldebaran Capital, LLC reduced stake in above stock

Sold off

Ticker$ Sold
essa pharma inc-984,196
ikena oncology inc-324,435
procter and gamble co-200,814

Aldebaran Capital, LLC got rid off the above stocks

Sector Distribution

Aldebaran Capital, LLC has about 44.8% of it's holdings in Others sector.

Sector%
Others44.8
Energy13.2
Healthcare10.5
Technology10.3
Financial Services8.8
Consumer Cyclical5.6
Basic Materials3.5
Communication Services2.6

Market Cap. Distribution

Aldebaran Capital, LLC has about 41.6% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED44.8
MEGA-CAP26.9
LARGE-CAP14.7
MICRO-CAP10.4
SMALL-CAP1.9
MID-CAP1.3

Stocks belong to which Index?

About 53.3% of the stocks held by Aldebaran Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others46.7
S&P 50039.7
RUSSELL 200013.6
Top 5 Winners (%)%
AMLX
amylyx pharmaceuticals inc
112.0 %
CENX
century alum co
62.9 %
CATO
cato corp new
49.8 %
ACRS
aclaris therapeutics inc
33.8 %
PMVP
pmv pharmaceuticals inc
32.1 %
Top 5 Winners ($)$
AMLX
amylyx pharmaceuticals inc
1.6 M
CATO
cato corp new
1.5 M
OXY
occidental pete corp
0.9 M
CENX
century alum co
0.7 M
ACRS
aclaris therapeutics inc
0.5 M
Top 5 Losers (%)%
FCX
freeport-mcmoran inc
-9.4 %
MBIN
merchants bancorp ind
-3.8 %
LLY
lilly eli & co
-2.1 %
Top 5 Losers ($)$
FCX
freeport-mcmoran inc
-0.2 M
LLY
lilly eli & co
-0.1 M
MBIN
merchants bancorp ind
0.0 M

Aldebaran Capital, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Aldebaran Capital, LLC

Aldebaran Capital, LLC has 33 stocks in it's portfolio. About 71.1% of the portfolio is in top 10 stocks. FCX proved to be the most loss making stock for the portfolio. AMLX was the most profitable stock for Aldebaran Capital, LLC last quarter.

Last Reported on: 10 Nov, 2025
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions